Radioimmunotherapy in Oncology: Overview of the Last Decade Clinical Trials
The specific irradiation of tumors with selective radiolabeled antibodies constitutes an attractive therapeutic approach. Consequent preclinical research has been conducted by both biologists to identify pertinent targets and to select corresponding antibodies (mAb) and by radiochemists to radiolabe...
Enregistré dans:
Auteurs principaux: | Aurélie Rondon, Jacques Rouanet, Françoise Degoul |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/84b9eabcb1ee4a7680734cf6d002e4ee |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The natural sulfoglycolipid derivative SQAP improves the therapeutic efficacy of tissue factor-targeted radioimmunotherapy in the stroma-rich pancreatic cancer model BxPC-3
par: Yoichi Takakusagi, et autres
Publié: (2022) -
Immunotherapy and Radioimmunotherapy for Desmoplastic Small Round Cell Tumor
par: Madelyn Espinosa-Cotton, et autres
Publié: (2021) - Oncolog-Hematolog
- Romanian Journal of Oncology & Hematology
-
Scope of Artificial Intelligence in Gastrointestinal Oncology
par: Hemant Goyal, et autres
Publié: (2021)